Millennium Management
ACET icon

Millennium Management’s Adicet Bio ACET Stock Holding History

Millennium Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,372
Closed -$459K – 5952
2025
Q3 		$459K Sell
35,372
-1,648
-4% -$19.4K ﹤0.01% 5125
2025
Q2 		$361K Sell
37,020
-39,472
-52% -$416K ﹤0.01% 5096
2025
Q1 		$924K Sell
76,492
-36,903
-33% -$528K ﹤0.01% 4406
2024
Q4 		$1.75M Sell
113,395
-9,025
-7% -$170K ﹤0.01% 3759
2024
Q3 		$2.82M Sell
122,420
-103,934
-46% -$2.33M ﹤0.01% 3373
2024
Q2 		$4.38M Sell
226,354
-30,282
-12% -$811K ﹤0.01% 2845
2024
Q1 		$9.65M Buy
256,636
+174,037
+211% +$7.2M ﹤0.01% 2223
2023
Q4 		$2.5M Buy
82,599
+26,731
+48% +$583K ﹤0.01% 3422
2023
Q3 		$1.22M Buy
55,868
+7,138
+15% +$252K ﹤0.01% 4021
2023
Q2 		$1.89M Buy
48,730
+38,050
+356% +$3.36M ﹤0.01% 3526
2023
Q1 		$984K Buy
10,680
+5,906
+124% +$741K ﹤0.01% 4112
2022
Q4 		$683K Buy
+4,774
New +$1.19M ﹤0.01% 4501
2022
Q3 		– Sell
-8,042
Closed -$2.04M – 7009
2022
Q2 		$1.88M Buy
+8,042
New +$1.77M ﹤0.01% 3767
2021
Q4 		– Sell
-1,422
Closed -$178K – 6699
2021
Q3 		$178K Sell
1,422
-4,538
-76% -$563K ﹤0.01% 6180
2021
Q2 		$981K Sell
5,960
-5,293
-47% -$1.08M ﹤0.01% 4683
2021
Q1 		$2.35M Buy
11,253
+9,873
+715% +$2.27M ﹤0.01% 3378
2020
Q4 		$310K Buy
+1,380
New +$283K ﹤0.01% 4525
2020
Q2 		– Sell
-886
Closed -$102K – 4118
2020
Q1 		$102K Sell
886
-2,938
-77% -$436K ﹤0.01% 3545
2019
Q4 		$638K Buy
3,824
+3,474
+993% +$1.76M ﹤0.01% 3232
2019
Q3 		$346K Buy
+350
New +$391K ﹤0.01% 3482
2018
Q4 		– Sell
-2,076
Closed -$3.52M – 3697
2018
Q3 		$3.52M Buy
+2,076
New +$2.71M ﹤0.01% 2048

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Millennium Management's ACET Position: Q4 2025 in Review

Millennium Management sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 35,372 shares — an estimated $459K sold.

Millennium Management first reported a position in ACET in Q3 2018 and held it in 21 quarters. The position peaked at $9.65M in Q1 2024. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Millennium Management reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Millennium Management sold 35,372 Adicet Bio shares in Q4 2025, an estimated $459K.
  • Millennium Management first reported a position in Adicet Bio in Q3 2018 and held it in 21 quarters.
  • Millennium Management's Adicet Bio position peaked at $9.65M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.